PMID- 35195585
OWN - NLM
STAT- MEDLINE
DCOM- 20220407
LR  - 20230925
IS  - 1536-0229 (Electronic)
IS  - 0363-9762 (Linking)
VI  - 47
IP  - 5
DP  - 2022 May 1
TI  - 68Ga-DOTANOC PET/CT in Multiple Endocrine Neoplasia 1 With Associated 
      Adrenocortical Carcinoma.
PG  - e389-e392
LID - 10.1097/RLU.0000000000004102 [doi]
AB  - Multiple endocrine neoplasia 1 (MEN1) syndrome is an autosomal dominant syndrome 
      comprising a triad of pancreatic, pituitary, and parathyroid tumors. Adrenal 
      cortical carcinoma occurs rarely in MEN1 syndrome. Here, we have presented a case 
      of a 62-year-old woman with adrenal mass and elevated serum parathormone levels, 
      who underwent 68Ga-DOTANOC PET/CT. 68Ga-DOTANOC PET/CT showed intense tracer 
      concentration in the left adrenal mass and lesions in the liver, pancreas, and 
      peritoneum. Biopsy of the peritoneal deposit revealed metastatic adrenocortical 
      carcinoma, and further genetic testing showed MEN1 mutation.
CI  - Copyright (c) 2022 Wolters Kluwer Health, Inc. All rights reserved.
FAU - Basheer, Shyma
AU  - Basheer S
FAU - Ratheesan, Ramkesh
AU  - Ratheesan R
AD  - Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
FAU - Sarma, Manjit
AU  - Sarma M
FAU - Palaniswamy, Shanmuga Sundaram
AU  - Palaniswamy SS
FAU - Mathews, Anitha
AU  - Mathews A
AD  - Department of Pathology, Regional Cancer Centre, Trivandrum, Kerala, India.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Clin Nucl Med
JT  - Clinical nuclear medicine
JID - 7611109
RN  - 0 (68Ga-DOTANOC)
RN  - 0 (Organometallic Compounds)
SB  - IM
MH  - *Adrenal Cortex Neoplasms/complications/diagnostic imaging
MH  - *Adrenocortical Carcinoma/complications/diagnostic imaging
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - *Multiple Endocrine Neoplasia/complications
MH  - *Multiple Endocrine Neoplasia Type 1/complications/diagnostic imaging
MH  - Organometallic Compounds
MH  - Positron Emission Tomography Computed Tomography
COIS- Conflicts of interest and sources of funding: none declared.
EDAT- 2022/02/24 06:00
MHDA- 2022/04/08 06:00
CRDT- 2022/02/23 12:26
PHST- 2022/02/24 06:00 [pubmed]
PHST- 2022/04/08 06:00 [medline]
PHST- 2022/02/23 12:26 [entrez]
AID - 00003072-202205000-00029 [pii]
AID - 10.1097/RLU.0000000000004102 [doi]
PST - ppublish
SO  - Clin Nucl Med. 2022 May 1;47(5):e389-e392. doi: 10.1097/RLU.0000000000004102.